You keep throwing stuff together, seemingly without understanding the terms you use. There's no media pushing for 7B because there's no global medium. If you c

You keep throwing stuff together, seemingly without understanding the terms you use. There's no media pushing for 7B because there's no global medium. If you count the nation-wide newspapers and add the numbers you'll end up with about 7B, modulo nations that have no free media, of course. People that don't want vaccinations will at some point be treated like people that don't want blood transfusion. Sad, but it's their choice. IP legislation has nothing to do with any lack of doses. The BionTech vaccine could be manufactured in one plant for world-wide consumption, if needed. The current pace is dictated by supply chain constraints, manufacturing setup effort, orders, and distribution. Any other vendor would face the very se issue. If someone would want to order an additional billion of doses, BionTech/Pfizer could certainly deliver. In fact, there are so many ways to code the spike protein that there's no way IP is preventing other vendors from setting up a competing product. It's manufacturing experience that makes the difference now.